Merovan Iv

Meropenem, the active ingredient in Merovan Iv, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, septicemia, and skin and soft‑tissue infections in hospitalized patients.

GNH USA supplies Merovan Iv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used to treat severe infections caused by susceptible bacteria.

- Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure. - Complicated urinary tract infections: resolves infection and prevents progression. - Nosocomial pneumonia: treats hospital‑acquired lung infection. - Septicemia: clears bloodstream infection. - Skin and soft tissue infections: eliminates causative organisms.

Adverse reactions to Merovan Iv may vary in frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Headache - Infusion site phlebitis

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reactions - Clostridioides difficile‑associated colitis - Seizures, especially at high doses or in patients with CNS disorders - Renal impairment or nephrotoxicity

When using Merovan Iv, clinicians should consider several safety measures.

- Renal function: adjust dosing in patients with impaired renal clearance. - Hypersensitivity: avoid in individuals with known carbapenem allergy. - Seizure risk: monitor patients with central nervous system disorders or receiving high doses. - C. difficile risk: limit use to confirmed infections to reduce colitis risk. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines; awareness of interaction severity is important.

Major Interactions (Avoid): - Valproic acid: concurrent use may lower valproate levels and precipitate seizures. - Probenecid: can increase meropenem concentrations, raising toxicity risk. - Renal toxic drugs (e.g., aminoglycosides): additive nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase risk of ototoxicity. - Anticoagulants (warfarin): infection and drug may alter INR; monitor coagulation. - Oral contraceptives: infection may reduce efficacy; advise backup contraception.